Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
|Videos|July 7, 2021
3 Questions for Dr. Paul Offit on COVID-19 Vaccines for Children
Author(s)Lois Levine, MA
Advertisement
Editor’s note: Dr. Paul Offit, MD, is the Director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, as well as an internationally recognized expert in the fields of virology and immunology. He is also the co-inventor of a landmark vaccine achievment for the prevention of rotavirus gastroenteritis.
We recently spoke with Dr. Offit about the COVID-19 vaccine in children aged less than 12 years; vaccine hesitators vs vaccine cynics; and who should be administering the COVID-19 vaccines for children.
Advertisement
Related to this article
Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.
Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.
Hai D. Nguyen-Tran, MD, discusses clinical signs, neurologic warning symptoms, supportive care, and preventing the spread of hand, foot, and mouth disease.
Todd Wolynn, MD, MMM, FAAP, explains how pediatricians can address misinformation through empathetic communication and community engagement.
Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.
An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.
A clinician-reported misinformation tracker at Children's Hospital of Philadelphia found vaccines accounted for 53.8% of 234 entries and informed education on 28 topics.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Hand, foot, and mouth disease: Red flags pediatricians should know
2
Infant skin care: Choosing products that protect the skin barrier
3
Mirikizumab meets 1-year remission end point in pediatric UC
4
Contemporary Pediatrics week in review: October 12-16, 2026
5